Diseases, Conditions, Syndromes

Vaccine is a cost-effective solution for countries burdened by typhoid

Introducing a typhoid conjugate vaccine (TCV) into routine child vaccine schedules and conducting a catch-up campaign to vaccinate all children up to age 15 is a cost-effective solution for many low- to middle-income countries ...

Diseases, Conditions, Syndromes

UMSOM and GRAS begin second typhoid conjugate vaccine study in Africa

A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine (TCV). It is the second clinical study underway in Africa for the vaccine and the first in West Africa. The vaccine study is a joint ...

Diseases, Conditions, Syndromes

Some gut bacteria may protect against intestinal infection

Scientists at the University of Maryland School of Medicine have for the first time found evidence that the presence of a key species in the human gut microbiome is associated with protection from infection with typhoid fever. ...

Diseases, Conditions, Syndromes

WHO recommends use of first typhoid conjugate vaccine

The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid ...

page 3 from 5